These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8416877)

  • 1. Relative clinical influence of tumor dose versus dose per fraction on the occurrence of late normal tissue morbidity following larynx radiotherapy.
    Slevin NJ; Vasanthan S; Dougal M
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(1):23-8. PubMed ID: 8416877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
    Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx?
    Fein DA; Lee WR; Hanlon AL; Ridge JA; Curran WJ; Coia LR
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):823-31. PubMed ID: 8598359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control.
    Fein DA; Mendenhall WM; Parsons JT; Million RR
    Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):605-11. PubMed ID: 8454477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
    Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
    Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy of early-stage glottic cancer: analysis of factors affecting prognosis.
    Chen MF; Chang JT; Tsang NM; Liao CT; Chen WC
    Ann Otol Rhinol Laryngol; 2003 Oct; 112(10):904-11. PubMed ID: 14587984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advantage of accelerated fractionation regimens in definitive radiotherapy for stage II glottic carcinoma.
    Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
    Ann Otol Rhinol Laryngol; 2006 Oct; 115(10):727-32. PubMed ID: 17076093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of treatment time and smoking on local control and complications in T1 glottic cancer.
    van der Voet JC; Keus RB; Hart AA; Hilgers FJ; Bartelink H
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):247-55. PubMed ID: 9788401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord.
    Lee JH; Machtay M; McKenna MG; Weinstein GS; Markiewicz DA; Krisch RE; Kligerman MM
    Am J Otolaryngol; 2001; 22(1):43-54. PubMed ID: 11172214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional fractionation should not be the standard of care for T2 glottic cancer.
    Dixon LM; Douglas CM; Shaukat SI; Garcez K; Lee LW; Sykes AJ; Thomson D; Slevin NJ
    Radiat Oncol; 2017 Nov; 12(1):178. PubMed ID: 29137654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis.
    Rudoltz MS; Benammar A; Mohiuddin M
    Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):767-72. PubMed ID: 8344844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.
    Canaday DJ; Regine WF; Mohiuddin M; Zollinger W; Machtay M; Lee J; Schultz D; Rudoltz MS
    Radiat Oncol Investig; 1999; 7(1):42-8. PubMed ID: 10030623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control.
    Sakata K; Aoki Y; Karasawa K; Hasezawa K; Muta N; Nakagawa K; Terahara A; Onogi Y; Sasaki Y; Akanuma A
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1059-64. PubMed ID: 7961012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease.
    Frata P; Cellai E; Magrini SM; Bonetti B; Vitali E; Tonoli S; Buglione M; Paiar F; Barca R; Fondelli S; Polli C; Livi L; Biti G
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1387-94. PubMed ID: 16115737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitive radiotherapy for carcinoma in situ of the true vocal cords.
    Sengupta N; Morris CG; Kirwan J; Amdur RJ; Mendenhall WM
    Am J Clin Oncol; 2010 Feb; 33(1):94-5. PubMed ID: 19738453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy in early glottic carcinoma.
    Kanonier G; Fritsch E; Rainer T; Thumfart WF
    Ann Otol Rhinol Laryngol; 1996 Oct; 105(10):759-63. PubMed ID: 8865769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
    Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
    Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of p53 protein does not predict local-regional control or survival in patients with early-stage squamous cell carcinoma of the glottic larynx treated with radiotherapy.
    Pai HH; Rochon L; Clark B; Black M; Shenouda G
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):37-42. PubMed ID: 9588915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcome of Definitive Radiotherapy for Early Glottic Cancer: Prognostic Factors and Patterns of Local Failure.
    Lim YJ; Wu HG; Kwon TK; Hah JH; Sung MW; Kim KH; Park CI
    Cancer Res Treat; 2015 Oct; 47(4):862-70. PubMed ID: 25687859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative clinical influence of tumor dose versus dose per fraction on the local control and late normal-tissue morbidity after larynx radiotherapy.
    Million RR
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(1):149-50. PubMed ID: 8416872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.